| Polyomavirus and related diseases | Lifetime | 16 | DE 2 | 99.63 |
| Multiple Sclerosis Research Studies | Lifetime | 25 | DE 3 | 99.76 |
| Peripheral Neuropathies and Disorders | Lifetime | 20 | DE 3 | 99.72 |
| Myasthenia Gravis and Thymoma | Lifetime | 21 | DE 2 | 99.34 |
| Cytokine Signaling Pathways and Interactions | Lifetime | 150 | DE 11 | 98.97 |
| Hereditary Neurological Disorders | Lifetime | 43 | DE 4 | 98.94 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 231 | DE 25 | 99.07 |
| Reproductive System and Pregnancy | Lifetime | 284 | DE 11 | 98.29 |
| Immunotherapy and Immune Responses | Lifetime | 786 | DE 68 | 98.78 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 55 | DE 6 | 97.76 |
| Long-Term Effects of COVID-19 | Lifetime | 404 | DE 16 | 96.86 |
| Peripheral Nerve Disorders | Lifetime | 212 | DE 9 | 97.12 |
| Pregnancy and Medication Impact | Lifetime | 392 | DE 11 | 95.94 |
| Nerve injury and regeneration | Lifetime | 883 | DE 68 | 95.48 |
| Sphingolipid Metabolism and Signaling | Lifetime | 372 | DE 51 | 94.59 |
| Fungal Plant Pathogen Control | Lifetime | 557 | DE 25 | 92.03 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 686 | DE 31 | 91.93 |
| Phagocytosis and Immune Regulation | Lifetime | 843 | DE 67 | 89.85 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 778 | DE 15 | 75.82 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 620 | DE 36 | 77.48 |
| Multiple Sclerosis Research Studies | 2021-2025 | 33 | DE 4 | 99.26 |
| Polyomavirus and related diseases | 2021-2025 | 49 | DE 7 | 96.50 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 118 | DE 16 | 96.32 |
| Long-Term Effects of COVID-19 | 2021-2025 | 978 | DE 52 | 92.98 |
| Peripheral Nerve Disorders | 2021-2025 | 85 | DE 7 | 92.33 |
| Hereditary Neurological Disorders | 2021-2025 | 72 | DE 10 | 92.02 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 113 | DE 15 | 92.79 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 85 | DE 12 | 88.45 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 856 | DE 71 | 88.93 |
| Pregnancy and Medication Impact | 2021-2025 | 431 | DE 14 | 83.48 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 589 | DE 37 | 73.17 |
| Neurogenesis and neuroplasticity mechanisms | 2021-2025 | 925 | DE 73 | 68.09 |